Clinical epidemiology of multiple sclerosis and inflammatory joint diseases – Team Thomas Frisell

We develop and apply epidemiological methods, aiming to generate knowledge that can aid patients and caregivers in understanding the impact and prognosis of chronic inflammatory diseases, and in making informed choices about therapeutic options.

Clinical epidemiology of multiple sclerosis and inflammatory joint diseases

Team Frisell is a methodologically oriented part of Johan Askling's research group on chronic inflammatory disease epidemiology. Working closely with clinical experts, our expertise lies in study design, biostatistical methods, and how to make the most of registers and other secondary data sources for clinical epidemiology. Motivated by the value our studies can bring people living with rheumatic or neurological chronic inflammatory diseases, we see it as our job to find the right methodological tool to maximize the contribution of each research project.

Team members are active in teaching, primarily on the post-graduate level, and our studies include epidemiological projects on the causes of diseases and to describe changing patient population, clinical projects aiming to identify prognostic markers, monitor the safety of treatments, and support clinical decision-making, and more directly methodological projects to validate data sources or evaluate statistical methods. We are mostly active in research on multiple sclerosis, rheumatoid arthritis and spondyloarthritits, but the methods we use can be applied to any chronic disease.


Selected publications


  • The Swedish Research Council
  • Forte
  • Patient Centered Outcomes Institute (PCORI)
  • The US Department of Defence
  • Karolinska Institutet
  • NEURO Sweden
  • Reumatikerfonden
Neurology Public Health, Global Health, Social Medicine and Epidemiology Rheumatology and Autoimmunity
Content reviewer: